Target intelligence / Profile preview

DSTN pseudogene 3 (DSTNP3)

Target
DSTNP3
Molecular classification
Other (Pseudogene; by definition, not an enzyme, receptor, transporter, or other active protein-coding molecule)
01

Overview

DSTN pseudogene 3 (DSTNP3) is a human pseudogene located on Chromosome 8 at position 8q21.11[1][5][8]. It is a non-coding genetic segment related to the DSTN gene (destrin, actin depolymerizing factor), but it does not encode a functional protein and is not known to play a direct role in physiological processes or diseases. Pseudogenes like DSTNP3 typically arise from ancestral genes but accumulate mutations such that they lose protein-coding potential; they are generally not considered therapeutic targets[7][8].

Other names
destrin (actin depolymerizing factor) pseudogene 3DSTN pseudogene 3AC022868.1destrin, actin depolymerizing factor pseudogene 3
02

Mechanism of action

null (not a druggable or functional target)

03

Biological functions

None documented (pseudogene; does not encode a functional protein)
04

Disease associations

None documented (pseudogene; no direct involvement in disease)
05

Safety considerations

None (not a therapeutic target)
06

Interacting drugs

None (no drugs documented to interact with DSTNP3)
07

Biomarkers

None (not used as a biomarker)

Beyond the preview

Go deeper on DSTN pseudogene 3 (DSTNP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DSTN pseudogene 3 (DSTNP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call